NASDAQ:CBIO - Nasdaq - US14888D2080 - Common Stock - Currency: USD
TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 794.00K | 7.34M | 20.95M | 0.00 | |||
Cost Of Goods | 0.00 | 798.00K | 7.38M | 9.16M | N/A | |||
Gross Profit | 0.00 | -4.00K | -42.00K | 11.79M | N/A | |||
Operating Expenses | 13.55M | 29.40M | 87.85M | 68.36M | 57.28M | |||
Research and Development | 1.98M | 12.44M | 68.89M | 52.18M | 43.86M | |||
Selling, General, and Administrative Expenses | 12.77M | 16.97M | 18.96M | 16.18M | 13.42M | |||
Operating Income | -13.55M | -29.41M | -87.89M | -56.57M | -57.28M | |||
Interest Income/Expense | 383.00K | 537.00K | 39.00K | 560.00K | 2.15M | |||
Other Income/Expense | N/A | 0.00 | -78.00K | 570.00K | -50.00K | |||
Non Recurring Items | -30.71M | 20.98M | N/A | -800.00K | N/A | |||
Income Before Taxes | -43.88M | -7.89M | -87.93M | -56.24M | -55.18M | |||
Income Tax | 364.00K | 348.00K | N/A | N/A | N/A | |||
Net Income | -44.24M | -8.24M | -87.93M | -56.24M | -55.18M | |||
EBITDA | N/A | -29.18M | -87.60M | -56.47M | -57.18M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.37 | -0.26 | -2.87 | -2.93 | -4.60 | |||
Non GAAP EPS | N/A | N/A | -2.87 | -2.83 | -4.60 | |||
Statistics | ||||||||
Gross Profit Margin | N/A | -0.50% | -0.57% | 56.28% | N/A | |||
Profit Margin | N/A | -1038.04% | -1198.32% | -268.45% | N/A | |||
Operating Profit Margin | N/A | -3703.65% | -1197.79% | -270.02% | N/A |
All data in USD